First 100 days of pandemic; an interplay of pharmaceutical, behavioral and digital interventions -- A study using agent based modeling
Gauri Gupta, Ritvik Kapila, Ayush Chopra, Ramesh Raskar
TL;DR
This paper demonstrates that agent-based models can capture the nuanced interplay of pharmaceutical, behavioral, and digital interventions during a pandemic, using a 100k-agent Kings County, WA population over 180 days. It introduces a vectorized ABM framework with four interventions—Testing, Self-quarantine, Vaccination, and Contact Tracing (including digital and manual variants)—and evaluates their standalone and combined effects. Key findings show that the initial 100 days largely shape the pandemic's trajectory, and that integrating behavioral and digital strategies with vaccination significantly reduces infections and delays the peak, often with superior cost-effectiveness to vaccination alone. The work provides a practical decision-support framework with a configurable pipeline and real-world data, highlighting policy implications for rapid, multi-pronged pandemic responses.
Abstract
Pandemics, notably the recent COVID-19 outbreak, have impacted both public health and the global economy. A profound understanding of disease progression and efficient response strategies is thus needed to prepare for potential future outbreaks. In this paper, we emphasize the potential of Agent-Based Models (ABM) in capturing complex infection dynamics and understanding the impact of interventions. We simulate realistic pharmaceutical, behavioral, and digital interventions that mirror challenges in real-world policy adoption and suggest a holistic combination of these interventions for pandemic response. Using these simulations, we study the trends of emergent behavior on a large-scale population based on real-world socio-demographic and geo-census data from Kings County in Washington. Our analysis reveals the pivotal role of the initial 100 days in dictating a pandemic's course, emphasizing the importance of quick decision-making and efficient policy development. Further, we highlight that investing in behavioral and digital interventions can reduce the burden on pharmaceutical interventions by reducing the total number of infections and hospitalizations, and by delaying the pandemic's peak. We also infer that allocating the same amount of dollars towards extensive testing with contact tracing and self-quarantine offers greater cost efficiency compared to spending the entire budget on vaccinations.
